EU advocate general backs MSD and Commission in drug advertising case
This article was originally published in SRA
Executive Summary
An advocate general of the EU Court of Justice has declared that a pharmaceutical company can make information about its drugs publicly available without contravening the EU ban on advertising prescription medicines to the public, provided that information has been approved by the appropriate regulatory authorities1.